| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 5 |
| 1 | CLINDAMYCIN | 4 |
| 2 | CLINDAMYCIN PHOSPHATE | 4 |
| 3 | METHOTREXATE | 4 |
| 4 | METHOTREXATE SODIUM | 4 |
| 5 | SECUKINUMAB | 4 |
| 6 | SPIRONOLACTONE | 4 |
| 7 | ANAKINRA | 3 |
| 8 | BURN RELIEF | 3 |
| 9 | DAPSONE | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NITAZOXANIDE | 2 | 0.0057 |
| 1 | CLINDAMYCIN PHOSPHATE | 4 | 0.0007 |
| 2 | FINERENONE | 1 | 0.0003 |
| 3 | DASPONE | 3 | 0.0003 |
| 4 | DAPSONE GEL, 5% | 3 | 0.0003 |
| 5 | DAPSONE | 3 | 0.0003 |
| 6 | ANAKINRA | 3 | 0.0002 |
| 7 | LIDICAINE | 3 | 0.0001 |
| 8 | ISOTRETINOIN | 3 | 0.0001 |
| 9 | LIDOCAINE, MENTHOL | 3 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 2 | Sulfone [EPC] | 3 | 0.0003 |
| 3 | Antiprotozoal [EPC] | 2 | 0.0002 |
| 4 | Interleukin-1 Receptor Antagonist [EPC] | 3 | 0.0002 |
| 5 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |
| 6 | Interleukin-17A Antagonist [EPC] | 4 | 0.0001 |
| 7 | Ester Local Anesthetic [EPC] | 3 | 0.0001 |
| 8 | Tetracycline-class Drug [EPC] | 3 | 0.0000 |
| 9 | Non-Standardized Chemical Allergen [EPC] | 3 | 0.0000 |